These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27993614)

  • 1. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
    Wallis CL; Viana RV; Saravanan S; Silva de Jesus C; Zeh C; Halvas EK; Mellors JW
    J Virol Methods; 2017 Mar; 241():41-45. PubMed ID: 27993614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance comparison of an in-house integrase genotyping assay versus the ViroSeq™ Integra48, and study of HIV-1 integrase polymorphisms in Hong Kong.
    To SW; Chen JH; Wong KH; Chan KC; Ng HM; Wu H; Lam JT; Yam WC
    J Clin Virol; 2013 Sep; 58(1):299-302. PubMed ID: 23886504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
    Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
    Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of an in-house 'home-brew' and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples.
    Seatla KK; Choga WT; Mogwele M; Diphoko T; Maruapula D; Mupfumi L; Musonda RM; Rowley CF; Avalos A; Kasvosve I; Moyo S; Gaseitsiwe S
    PLoS One; 2019; 14(11):e0224292. PubMed ID: 31751353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HIV-1 integrase genotype assay for the detection of drug resistance mutations.
    Hearps AC; Greengrass V; Hoy J; Crowe SM
    Sex Health; 2009 Dec; 6(4):305-9. PubMed ID: 19917199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors.
    Brenner BG; Lowe M; Moisi D; Hardy I; Gagnon S; Charest H; Baril JG; Wainberg MA; Roger M
    J Med Virol; 2011 May; 83(5):751-9. PubMed ID: 21360548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance.
    Lataillade M; Chiarella J; Kozal MJ
    Antivir Ther; 2007; 12(4):563-70. PubMed ID: 17668566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes.
    Van Laethem K; Schrooten Y; Covens K; Dekeersmaeker N; De Munter P; Van Wijngaerden E; Van Ranst M; Vandamme AM
    J Virol Methods; 2008 Nov; 153(2):176-81. PubMed ID: 18706932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance-Associated Mutations and Polymorphisms among Integrase Inhibitor-Naïve HIV-1 Patients in Kuwait.
    Chehadeh W; Albaksami O; John SE; Al-Nakib W
    Intervirology; 2017; 60(4):131-137. PubMed ID: 29212076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Integrase Strand Transfer Inhibitor Associated Resistance in Antiretroviral Therapy Naïve and Experienced Individuals from Western India.
    Karade S; Sen S; Sashindran VK
    AIDS Res Hum Retroviruses; 2019 Jun; 35(6):567-571. PubMed ID: 30793915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil.
    Passaes CB; Guimarães ML; Fernandez SL; Lorete Rdos S; Teixeira SL; Fernandez JC; Morgado MG
    J Acquir Immune Defic Syndr; 2009 May; 51(1):7-12. PubMed ID: 19262402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].
    Yalçınkaya T; Köse S
    Mikrobiyol Bul; 2014 Oct; 48(4):585-95. PubMed ID: 25492654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda.
    McCluskey SM; Kamelian K; Musinguzi N; Kigozi S; Boum Y; Bwana MB; Muzoora C; Brumme ZL; Carrington M; Carlson J; Foley B; Hunt PW; Martin JN; Bangsberg DR; Harrigan PR; Siedner MJ; Haberer JE; Lee GQ
    AIDS; 2021 Jun; 35(7):1083-1089. PubMed ID: 33635845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic barrier to the development of resistance to integrase inhibitors in HIV-1 subtypes CRF01_AE and B.
    Nguyen HL; Ruxrungtham K; Delaugerre C
    Intervirology; 2012; 55(4):287-95. PubMed ID: 22456540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatment.
    El Bouzidi K; Kemp SA; Datir RP; Murtala-Ibrahim F; Aliyu A; Kwaghe V; Frampton D; Roy S; Breuer J; Sabin CA; Ogbanufe O; Charurat ME; Bonsall D; Golubchik T; Fraser C; Dakum P; Ndembi N; Gupta RK
    J Antimicrob Chemother; 2020 Jun; 75(6):1575-1579. PubMed ID: 32105319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Genetic Diversity and Natural Polymorphisms of the Integrase Gene in Integrase Inhibitor-Naive Patients in Harare, Zimbabwe.
    Madyadi A; Dhoro M; Shamu T; Washaya T; Kouamou V; Chimukangara B; Katzenstein D; Manasa J
    AIDS Res Hum Retroviruses; 2021 Dec; 37(12):954-961. PubMed ID: 34714124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.
    Inzaule SC; Hamers RL; Noguera-Julian M; Casadellà M; Parera M; Rinke de Wit TF; Paredes R
    J Antimicrob Chemother; 2018 May; 73(5):1167-1172. PubMed ID: 29462322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in Russia and Predicted Susceptibility to INSTIs.
    Kirichenko A; Lapovok I; Baryshev P; van de Vijver DAMC; van Kampen JJA; Boucher CAB; Paraskevis D; Kireev D
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32752001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating HIV-1 Integrase Genotypes in Tanzania: Implication on the Introduction of Integrase Inhibitors-Based Antiretroviral Therapy Regimen.
    Masoud S; Kamori D; Barabona G; Mahiti M; Sunguya B; Lyamuya E; Ueno T
    AIDS Res Hum Retroviruses; 2020 Jun; 36(6):539-543. PubMed ID: 32126792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.